Salesforce reports Q1 FY2027 results today — and the pre-earnings short retreat described in last week's note has partially reversed, with a small but notable rebuild in bearish positioning over the final two sessions.
The short story has shifted modestly since the May 20 note. Short interest had fallen to 6.9% of the free float last week. It now stands at 6.74% — still lower, but the directional story has flipped: shorts added roughly 2.2% in a single day on May 26, partially unwinding the covering that dominated the prior week. In raw terms, estimated short interest climbed from around 62.8 million shares on May 25 back to 64.1 million. This isn't a dramatic rebuild — the figure remains well below the early-May peak near 9.1% — but it does suggest some participants chose to re-enter on the eve of the print rather than stay covered. Borrow costs ticked up 35% on the week to 0.53%, which is still historically low, and availability remains very loose at 581% of estimated short interest, so the lending market is imposing no friction on either side.
Options positioning has moved away from last week's extreme bullishness, though it hasn't flipped defensive. The put/call ratio stood at 0.79 on May 26 — roughly 1.5 standard deviations below its 20-day mean of 0.82, meaning calls still dominate, but the gap has narrowed sharply from the three-standard-deviation reading cited in the prior note. The 52-week range for the PCR runs from 0.52 to 0.88, and the current reading is comfortably in the middle. Together, short positioning and options tell the same story: residual caution rather than outright conviction on either side heading into the release.
The Street is more divided than the consensus headline implies. The overall analyst rating is technically "buy," but recent activity has been a string of trimmed targets and defensive repositioning. Bank of America reinstated with an Underperform and a $160 target on May 18 — one of the more pointed bearish calls among bellwether firms in recent weeks. UBS lowered its target from $200 to $185 while holding Neutral on May 21. Citi cut from $200 to $188, also Neutral, in mid-May. The mean price target of $261 implies substantial upside from the $179 close — but with BofA at $160 and multiple neutrals clustering in the $185–$200 range, the practical center of gravity on the Street is well below that mean. Bulls lean on the breadth of Salesforce's cloud portfolio and AI integration potential; bears point to intensifying pressure from Microsoft and Oracle and ongoing questions about mid-market pricing and acquisition-driven growth.
History offers one relevant data point: after the February 2026 Q4 print, the stock jumped 7.6% the next day and held most of that gain over the following week. That was the most recent prior earnings reaction. The setup then was different — shorts were less elevated, and options were less neutral — but the market's capacity to reward a clean beat is established.
What matters most in today's print is less whether revenue grows and more whether the AI monetisation story — Agentforce in particular — shows genuine enterprise adoption at scale. That's the number the Street will be stress-testing against the bear case.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
